title: Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.
authors.affiliation: School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: W Collins
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Chalmers
authors.forename: Daniel
authors.initials: D
authors.lastname: Hart
authors.forename: Ian
authors.initials: I
authors.lastname: Jennings
authors.forename: Ri
authors.initials: R
authors.lastname: Liesner
authors.forename: Savita
authors.initials: S
authors.lastname: Rangarajan
authors.forename: Kate
authors.initials: K
authors.lastname: Talks
authors.forename: Michael
authors.initials: M
authors.lastname: Williams
authors.forename: Charles
authors.initials: C
authors.lastname: R M Hay
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001778:Blood Coagulation Disorders / Q000175:diagnosis* / Q000628:therapy*; D019774:Blood Coagulation Factor Inhibitors; D005169:Factor VIII / Q000037:antagonists & inhibitors; D006801:Humans; D014841:von Willebrand Factor / Q000037:antagonists & inhibitors
chemical_list: D019774:Blood Coagulation Factor Inhibitors; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; D005169:Factor VIII
keywords: Factor VIII; acquired; autoimmune; coagulation factor; inhibitor